The relationship between childhood parental loss and metabolic syndrome in obese subjects

Alessandra Alciati1, Felice Gesuele, Giovanni Casazza

  • 1Department of Psychiatry, Luigi Sacco University Hospital, Milan, Italy. alessandra.alciati@libero.it

Insights

Childhood parental loss is linked to metabolic syndrome in severely obese adults. This early life stress may increase the risk of developing metabolic syndrome, impacting glucose and lipid metabolism.

Area of Science:

  • Endocrinology
  • Psychiatry
  • Public Health

Background:

  • Obesity is a global health concern, contributing to metabolic syndrome.
  • Early life stress is associated with weight gain and metabolic alterations.
  • Parental loss during childhood is a specific early adverse event under investigation.

Purpose of the Study:

  • To investigate the association between childhood parental loss and metabolic syndrome in severely obese individuals.
  • To identify risk factors for metabolic syndrome in patients undergoing bariatric surgery.

Main Methods:

  • Assessed 135 obese patients seeking bariatric surgery for metabolic syndrome using Adult Treatment Panel (ATP) III criteria.
  • Collected data on parental loss (separation or bereavement before age 17) via semi-structured interviews.
  • Utilized multivariate logistic regression analysis adjusted for age and gender.

Main Results:

  • 31.1% of the obese subjects met the criteria for metabolic syndrome.
  • Childhood parental loss and a body mass index (BMI) > 50 were significant predictors of metabolic syndrome.
  • No significant differences in demographics, health habits, or psychiatric diagnoses were found between groups.

Conclusions:

  • Childhood parental loss is preliminarily linked to an increased risk of developing metabolic syndrome.
  • This finding highlights the potential long-term impact of early life adversity on metabolic health.
  • Further research is warranted to confirm and explore this association.

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...